BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31419909)

  • 1. Conformational and Dynamical Effects of Tyr32 Phosphorylation in K-Ras: Molecular Dynamics Simulation and Markov State Models Analysis.
    Khaled M; Gorfe A; Sayyed-Ahmad A
    J Phys Chem B; 2019 Sep; 123(36):7667-7675. PubMed ID: 31419909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic G12D mutation alters local conformations and dynamics of K-Ras.
    Vatansever S; Erman B; Gümüş ZH
    Sci Rep; 2019 Aug; 9(1):11730. PubMed ID: 31409810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational Dynamics Allows Sampling of an "Active-like" State by Oncogenic K-Ras-GDP.
    Grudzien P; Jang H; Leschinsky N; Nussinov R; Gaponenko V
    J Mol Biol; 2022 Sep; 434(17):167695. PubMed ID: 35752212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct dynamics and interaction patterns in H- and K-Ras oncogenic P-loop mutants.
    Sayyed-Ahmad A; Prakash P; Gorfe AA
    Proteins; 2017 Sep; 85(9):1618-1632. PubMed ID: 28498561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition mechanism of MRTX1133 on KRAS
    Liang F; Kang Z; Sun X; Chen J; Duan X; He H; Cheng J
    J Comput Aided Mol Des; 2023 Mar; 37(3):157-166. PubMed ID: 36849761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
    Mazhab-Jafari MT; Marshall CB; Smith MJ; Gasmi-Seabrook GM; Stathopulos PB; Inagaki F; Kay LE; Neel BG; Ikura M
    Proc Natl Acad Sci U S A; 2015 May; 112(21):6625-30. PubMed ID: 25941399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR
    Yuan C; Hansen AL; Bruschweiler-Li L; Brüschweiler R
    Biomol NMR Assign; 2024 Jun; 18(1):7-13. PubMed ID: 37948018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative MD simulations and advanced analytics based studies on wild-type and hot-spot mutant A59G HRas.
    Sharma N; Sonavane U; Joshi R
    PLoS One; 2020; 15(10):e0234836. PubMed ID: 33064725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insight into the rearrangement of the switch I region in GTP-bound G12A K-Ras.
    Xu S; Long BN; Boris GH; Chen A; Ni S; Kennedy MA
    Acta Crystallogr D Struct Biol; 2017 Dec; 73(Pt 12):970-984. PubMed ID: 29199977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the Conformational and Energy Landscapes of KRAS Membrane Orientation.
    Prakash P; Gorfe AA
    J Phys Chem B; 2019 Oct; 123(41):8644-8652. PubMed ID: 31554397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting the structural flexibility of the complex p21(ras)-GTP: the catalytic conformation of the molecular switch II.
    Soares TA; Miller JH; Straatsma TP
    Proteins; 2001 Dec; 45(4):297-312. PubMed ID: 11746677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K-Ras Populates Conformational States Differently from Its Isoform H-Ras and Oncogenic Mutant K-RasG12D.
    Parker JA; Volmar AY; Pavlopoulos S; Mattos C
    Structure; 2018 Jun; 26(6):810-820.e4. PubMed ID: 29706533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel Imidazo[1,2-a]pyridine derivative modulates active KRAS
    Ali Y; Khan AA; Alanazi AM; Fatima S; Kozmon S
    Int J Biol Macromol; 2024 Jun; 270(Pt 2):132477. PubMed ID: 38772459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational landscape of K-Ras substitutions at 12th position-a systematic molecular dynamics approach.
    S UK; R B; D TK; Doss CGP; Zayed H
    J Biomol Struct Dyn; 2022 Mar; 40(4):1571-1585. PubMed ID: 33034275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Lapse in Druggability: Sequence Analysis, Structural Dynamics and Binding Site Characterization of K-RasG12C Variant, a Feasible Oncotherapeutics Target.
    Adeniji EA; Olotu FA; Soliman MES
    Anticancer Agents Med Chem; 2018; 18(11):1540-1550. PubMed ID: 30019652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GTP-Bound N-Ras Conformational States and Substates Are Modulated by Membrane and Point Mutation.
    Farcas A; Janosi L
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-Ras
    Feng H; Zhang Y; Bos PH; Chambers JM; Dupont MM; Stockwell BR
    Biochemistry; 2019 May; 58(21):2542-2554. PubMed ID: 31042025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical roles of interactions among switch I-preceding residues and between switch II and its neighboring alpha-helix in conformational dynamics of the GTP-bound Ras family small GTPases.
    Matsumoto K; Shima F; Muraoka S; Araki M; Hu L; Ijiri Y; Hirai R; Liao J; Yoshioka T; Kumasaka T; Yamamoto M; Tamura A; Kataoka T
    J Biol Chem; 2011 Apr; 286(17):15403-12. PubMed ID: 21388959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression.
    Al-Mulla F; Milner-White EJ; Going JJ; Birnie GD
    J Pathol; 1999 Mar; 187(4):433-8. PubMed ID: 10398103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalytically Competent Non-transforming H-RAS
    Ilter M; Sensoy O
    Sci Rep; 2019 Jul; 9(1):10967. PubMed ID: 31358828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.